227 related articles for article (PubMed ID: 26300163)
21. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
22. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
Yoo JW; Jo KW; Park GY; Shim TS
Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
[TBL] [Abstract][Full Text] [Related]
23. Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection.
Zhang C; Song X; Zhao Y; Zhang H; Zhao S; Mao F; Bai B; Wu S; Shi C
J Clin Lab Anal; 2015 Sep; 29(5):375-82. PubMed ID: 25131423
[TBL] [Abstract][Full Text] [Related]
24. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
[TBL] [Abstract][Full Text] [Related]
25. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants.
Carvalho AC; Pezzoli MC; El-Hamad I; Arce P; Bigoni S; Scarcella C; Indelicato AM; Scolari C; Carosi G; Matteelli A
J Infect; 2007 Aug; 55(2):164-8. PubMed ID: 17428542
[TBL] [Abstract][Full Text] [Related]
26. Predictors for a positive QuantiFERON-TB-Gold test in BCG-vaccinated adults with a positive tuberculin skin test.
Chawla H; Lobato MN; Sosa LE; ZuWallack R
J Infect Public Health; 2012 Dec; 5(6):369-73. PubMed ID: 23287606
[TBL] [Abstract][Full Text] [Related]
27. Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.
Alvarez-León EE; Espinosa-Vega E; Santana-Rodríguez E; Molina-Cabrillana JM; Pérez-Arellano JL; Caminero JA; Serrano-Aguilar P
Infect Control Hosp Epidemiol; 2009 Sep; 30(9):876-83. PubMed ID: 19614541
[TBL] [Abstract][Full Text] [Related]
28. QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.
Shovman O; Anouk M; Vinnitsky N; Arad U; Paran D; Litinsky I; Caspi D; Elkayam O
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1427-32. PubMed ID: 19861018
[TBL] [Abstract][Full Text] [Related]
29. LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis.
Della Bella C; Spinicci M; Alnwaisri HFM; Bartalesi F; Tapinassi S; Mencarini J; Benagiano M; Grassi A; D'Elios S; Troilo A; Abilbayeva A; Kuashova D; Bitanova E; Tarabayeva A; Shuralev EA; Bartoloni A; D'Elios MM
Int J Infect Dis; 2020 Feb; 91():177-181. PubMed ID: 31877486
[TBL] [Abstract][Full Text] [Related]
30. Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?
Dubaniewicz A; Holownia A; Kalinowski L; Wybieralska M; Dobrucki IT; Singh M
Hum Immunol; 2013 Jan; 74(1):45-51. PubMed ID: 23079237
[TBL] [Abstract][Full Text] [Related]
31. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
[TBL] [Abstract][Full Text] [Related]
32. [Lessons learned from tuberculosis outbreak cases].
Kato S; Kuwabara K
Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
[TBL] [Abstract][Full Text] [Related]
33. Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.
Hong Y; Kim Y; Lee JJ; Lee MG; Lee CY; Kim Y; Heo J; Han SS; Lee SJ; Kim WJ; Hong JY
BMC Infect Dis; 2019 Feb; 19(1):151. PubMed ID: 30760247
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
[TBL] [Abstract][Full Text] [Related]
35. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
36. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
James PM; Ganaie FA; Kadahalli RL
J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
[TBL] [Abstract][Full Text] [Related]
37. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
[TBL] [Abstract][Full Text] [Related]
38. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population.
Kariminia A; Sharifnia Z; Aghakhani A; Banifazl M; Eslamifar A; Hazrati M; Ramezani A
J Eval Clin Pract; 2009 Feb; 15(1):148-51. PubMed ID: 19239595
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
40. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
